Administrative Supplement - pHyCCAPP

行政补充 - pHyCCAPP

• 批准号: 10177381
• 负责人: MICHAEL OLIVIER
• 金额: $ 8.5万
• 依托单位: WAKE FOREST UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-18 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10177381
• 关键词: ATAC-seq; Administrative Supplement; Affect; Binding; Binding Proteins; CRISPR/Cas technology; Cell Line; Chromatin; DNA-Binding Proteins; Deoxyribonucleases; Development; Disease; Electrophoretic Mobility Shift Assay; Gene Expression; Gene Expression Regulation; Genes; High Pressure Liquid Chromatography; Human; Hypersensitivity; Individual; Intercistronic Region; Investigation; Laboratories; Luciferases; Mass Spectrum Analysis; Mediating; Methods; Molecular; Plasmids; Proteins; Proteomics; Quantitative Trait Loci; Reporter; Site; System; Technology; Variant; genetic analysis; genetic regulatory protein; genome sequencing; genome wide association study; improved; in vivo; new technology; novel; novel strategies; parent grant; promoter; rare variant; technology development; tool; trait; whole genome

Over the past decade, genome-wide association studies and comprehensive whole-genome sequencing analyses have uncovered both common and rare variants that are associated with a wide range of disease related traits. The majority of these associated variants lie in intergenic regions, and it has been suggested that they modulate the expression of individual genes. Indeed, genetic analyses have identified a large number of expression quantitative trait loci adjacent to the affected genes (cis-eQTL), and many sequence variants are strongly associated with both the expression of individual genes and disease-related traits. However, deciphering the underlying molecular mechanisms has been challenging. Traditional laboratory approaches, such as luciferase reporter constructs or electrophoretic mobility shift assays, as well as recent chromatin analyses (DNase hypersensitivity mapping, ATAC-Seq) clearly suggest a functional impact for disease associated promoter variants, but no effective methods exist to identify the regulatory proteins binding to these variant sites and mediating their effect on the regulation of gene expression. Therefore, alternative approaches are required to more efficiently identify these unknown regulatory proteins whose promoter binding and interaction is affected by eQTL variants. We recently developed a novel approach, Hybridization Capture of Chromatin-Associated Proteins for Proteomics (HyCCAPP), allows the identification of all proteins bound to a specific target chromatin region by mass spectrometry. We propose to adapt the HyCCAPP approach for the analysis of luciferase reporter plasmid constructs commonly used to assess the impact of sequence variants on promoter activity, and apply the technology to the analysis of selected eQTL promoter variants. We hypothesize that the HyCCAPP technology will uncover novel regulatory proteins mediating the effect of promoter variants on gene expression, revealing potentially novel molecular mechanisms underlying eQTLs. We will pursue three Specific Aims: 1) optimize HyCCAPP for the analysis of luciferase reporter plasmids, 2) analyze select promoter variants in eQTL regions using plasmid HyCCAPP, and 3) validate the impact of protein binding on gene expression in vivo in CRISPR-Cas9 edited cell lines. The technology development of HyCCAPP to target luciferase reporter plasmids, and a proof-of-principle application to promoter variants associated with gene expression changes, will establish a powerful new and effective tool for the investigation of the mechanisms by which regulatory sequence variants alter binding of regulatory proteins. No other current technology allows the effective de novo identification of DNA binding proteins affected by sequence variants. The use of commonly used luciferase reporter plasmid approaches with the new HyCCAPP technology will help reveal new mechanisms of gene expression regulation contributing to the development and progression of human disorders.

在过去的十年里，全基因组关联研究和全面的全基因组关联研究已经成为一个重要的研究领域。 测序分析已经发现了常见和罕见的变异，这些变异与广泛的 疾病相关的特征。大多数这些相关的变异体位于基因间区域， 表明它们调节单个基因的表达。事实上，基因分析已经确定了一个 大量与受影响基因相邻的表达数量性状位点（cis-eQTL），以及许多 序列变异与单个基因的表达和疾病相关的基因表达密切相关。 性状然而，破译潜在的分子机制一直具有挑战性。传统 实验室方法，如荧光素酶报告构建体或电泳迁移率变动测定，以及 最近的染色质分析（DNA酶超敏反应图谱，ATAC-Seq）清楚地表明， 影响疾病相关的启动子变异，但没有有效的方法来确定调控基因。 与这些变异位点结合并介导其对基因表达调控作用的蛋白质。 因此，需要替代方法来更有效地鉴定这些未知的调节蛋白 其启动子结合和相互作用受eQTL变体影响。 我们最近开发了一种新方法，染色质相关蛋白的杂交捕获， 蛋白质组学（HyCCAPP）允许通过以下方法鉴定与特定靶染色质区域结合的所有蛋白质： 质谱分析法来我们建议采用HyCCAPP方法分析荧光素酶报告基因 质粒构建体通常用于评估序列变体对启动子活性的影响，并应用 该技术用于分析所选eQTL启动子变体。我们假设HyCCAPP 这项技术将揭示新的调节蛋白，介导启动子变体对基因的影响， 表达，揭示了eQTL潜在的新分子机制。我们将追捕三名 具体目的：1）优化HyCCAPP用于荧光素酶报告质粒的分析，2）分析选择 使用质粒HyCCAPP在eQTL区域中的启动子变体，和3）验证蛋白质结合对 CRISPR-Cas9编辑的细胞系中的体内基因表达。面向目标的HyCCAPP技术开发 荧光素酶报告质粒和与基因相关的启动子变体的原理验证应用 表达的变化，将建立一个强大的新的和有效的工具，调查的机制， 所述调节序列变体改变调节蛋白的结合。目前没有其他技术允许 有效地从头鉴定受序列变体影响的DNA结合蛋白。常用的用法 使用荧光素酶报告质粒的方法与新的HyCCAPP技术将有助于揭示新的 基因表达调控机制有助于人类的发展和进步 紊乱